www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

Hepatitis C therapy to be improved

By Shan Juan | China Daily | Updated: 2016-12-14 07:31

Hepatitis C patients in China will soon be able to access direct-acting antiviral treatments, which can thoroughly cure the liver infection, a senior liver disease specialist said.

"Several DAA medicines are expected to get approval from the top drug authority and enter the Chinese market early next year, which will bring China's hepatitis C treatment in line with international mainstream practices," said Wei Lai, president of the Chinese Society of Liver Diseases of the Chinese Medical Association.

Currently, most Chinese patients are on injection interferon therapy, which takes longer and may cause serious reactions for some recipients.

DAA, by contrast, is taken orally and can usually get rid of the virus and cure the disease in about 12 weeks.

A patient surnamed Bai is one of those who cannot handle the major side effects from interferon treatment. To survive, he bought DAA drugs from overseas and was cured last year.

DAA medicines have been readily available elsewhere worldwide for many years. But the country with the most patients has no such drugs largely due to "complex and lengthy drug registration processes", according to WHO China Representative Bernhard Schwartlander.

In April, the China Food and Drug Administration announced an acceleration of the registration for DAA.

"That's encouraging, and Chinese patients will be able to access world-class treatments at home," Bai said.

Bai contracted the hepatitis C virus in the late 1980s via a blood transfusion. Viral screenings for hepatitis C and HIV were not integrated into the nation's blood donation drives until 1993, and a number of people became infected from blood transfusions in the late '80s and early '90s, Wei said.

"A majority of Chinese hepatitis C patients were infected during that period and they have now begun to develop cirrhosis of the liver and cancer," he said.

China has about 10 million people with hepatitis C - the highest worldwide - with nearly 60 percent of them becoming infected via blood-related procedures, statistics from the National Health and Family Planning Commission showed.

Other high risk procedures include dental services, endoscopy and dialysis, Wei said.

He urged the government to consider covering DAA under the health insurance program to improve patient access.

"Over the long run, it's cost effective, because treatment for cirrhosis of the liver and cancer costs much more," he said.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 一级a毛片 | 国产成人在线综合 | 国产三区视频在线观看 | 国产 magnet| 日本道久久 | 久久是精品 | 精品国产v无码大片在线观看 | 美女扒开腿让男人桶爽免费动态图 | 99在线精品视频免费观里 | 成人a毛片高清视频 | 国产亚洲精品资源一区 | 韩国精品一区二区三区四区五区 | 国内真实愉拍系列情侣 | 99re这里只有精品99 | 99re久久精品国产首页2020 | 久久久久久91香蕉国产 | 欧美视频精品在线 | 成人一区二区免费中文字幕 | 欧美成人一区二区三区 | 国产女人在线观看 | 欧美日韩精品一区二区三区视频播放 | 欧美亚洲中日韩中文字幕在线 | 91久久精品国产一区二区 | 国产精品日韩欧美一区二区三区 | 国产深夜福利视频网站在线观看 | 人成精品视频三区二区一区 | 亚洲精品中文字幕一区 | 中文字幕成人免费高清在线视频 | 亚洲欧美日韩精品永久在线 | 午夜剧场成年 | 亚洲精品人成网在线播放影院 | 手机在线黄色网址 | 男人女人做黄刺激性视频免费 | 国产v精品成人免费视频400条 | 1024国产欧美日韩精品 | 欧美一级特黄特色大片 | 中文字幕亚洲综合久久 | 欧美视频一区二区三区在线观看 | 欧美中文字幕一区二区三区 | 中文字幕一二区 | 波多野一区二区 |